BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
chemo pharma laboratories ltd. stock

CHEMO PHARMA LABORATORIES LTD. Share Price

119.29 -6.26 (-4.98%)
Dec 13 2024 03:23 PM Pharmaceuticals NSE: CHEMOPH

CHEMO PHARMA LABORATORIES LTD. Share Price Update

As of the latest trading session, CHEMO PHARMA LABORATORIES LTD. share price is currently at 119.29, which is down by -6.26 from its previous closing. Today, the stock has fluctuated between 119.29 and 128.70. Over the past year, CHEMO PHARMA LABORATORIES LTD. has achieved a return of 147.52 %. In the last month alone, the return has been 56.67 %. Read More...

CHEMO PHARMA LABORATORIES LTD. Performance

Day Range

Low119.29 High128.70
119.43

52 Week Range

Low 45.85 High 154.00
119.43

CHEMO PHARMA LABORATORIES LTD. Share Price

506365

CHEMOPH

img img img img
No Data Available

Open Price

128.70

Prev. Close

125.56

Volume (Shares)

2445.00

Total traded value

2.92

Upper Circuit

131.83

Lower Circuit

119.29

Note: The current prices & values are delayed, Login to your account for live updates.

CHEMO PHARMA LABORATORIES LTD. Fundamentals


(Standalone)

Market Cap (Cr) 17.89
PE Ratio (TTM) 14.42
Book Value / Share 91.06
Beta 0.58
ROE 9.84%
EPS (TTM) 8.28
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.61

CHEMO PHARMA LABORATORIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit 0.61
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 4.07
EBITDA 0.61
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.06
Net Profit 0.25
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 1.64
EBITDA 0.25
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.10
Net Profit -0.29
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.94
EBITDA 0.15
Effective Tax Rate (%) 293.33
Particulars DEC 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.03
Net Profit 0.68
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 4.51
EBITDA 0.68
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit 0.44
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 2.93
EBITDA 0.44
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.19
Net Profit 1.20
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 8.00
EBITDA 1.65
Effective Tax Rate (%) 26.82
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.22
Net Profit 0.05
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.32
EBITDA 0.08
Effective Tax Rate (%) 42.85
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.42
Net Profit 0.56
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 3.73
EBITDA 0.38
Effective Tax Rate (%) -55.55
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.36
Net Profit 0.25
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 1.67
EBITDA 0.33
Effective Tax Rate (%) 19.35
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 0.50
Net Profit 0.42
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 2.77
EBITDA 0.51
Effective Tax Rate (%) 16.32
Particulars MAR 2016 (Values in Cr)
Book Value / Share 24.49
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 85.35
ROE % 9.84
ROCE % 13.44
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 77.35
ROE % 0.43
ROCE % 0.78
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 77.03
ROE % 3.37
ROCE % 1.33
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 73.30
ROE % 2.30
ROCE % 2.85
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share 71.63
ROE % 3.99
ROCE % 4.75
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2016 (Values in Cr)
Cash & Short Term Investments 0.43
Total Assets 3.86
Total Liabilities 3.86
Total Equity 3.67
Share Outstanding 1500000
Price to Book Ratio 0.50
Return on Assets (%) -37.44
Return on Capital (%) -39.44
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 6.10
Total Assets 13.01
Total Liabilities 13.01
Total Equity 12.80
Share Outstanding 1500000
Price to Book Ratio 0.76
Return on Assets (%) 9.22
Return on Capital (%) 9.38
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.05
Total Assets 11.62
Total Liabilities 11.62
Total Equity 11.60
Share Outstanding 1500000
Price to Book Ratio 0.52
Return on Assets (%) 0.40
Return on Capital (%) 0.41
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.18
Total Assets 11.66
Total Liabilities 11.66
Total Equity 11.55
Share Outstanding 1500000
Price to Book Ratio 0.54
Return on Assets (%) 4.80
Return on Capital (%) 4.85
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 10.87
Total Assets 11.05
Total Liabilities 11.05
Total Equity 10.99
Share Outstanding 1500000
Price to Book Ratio 0.24
Return on Assets (%) 2.26
Return on Capital (%) 2.27
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 8.80
Total Assets 10.96
Total Liabilities 10.96
Total Equity 10.74
Share Outstanding 1500000
Price to Book Ratio 0.09
Return on Assets (%) 3.78
Return on Capital (%) 3.86
Particulars MAR 2024 (Values in Cr)
Net Income 1.64
Cash from Operations 0.89
Cash from Investing -0.52
Cash from Financing -0.14
Net change in Cash 0.04
Free Cash Flow 0.89
Particulars MAR 2023 (Values in Cr)
Net Income 0.07
Cash from Operations -0.67
Cash from Investing 0.62
Cash from Financing -0.07
Net change in Cash -0.13
Free Cash Flow -0.67
Particulars MAR 2022 (Values in Cr)
Net Income 0.36
Cash from Operations -0.26
Cash from Investing 0.96
Cash from Financing -2.12
Net change in Cash -1.48
Free Cash Flow -0.26
Particulars MAR 2021 (Values in Cr)
Net Income 0.31
Cash from Operations -0.32
Cash from Investing -0.18
Cash from Financing 1.95
Net change in Cash 1.36
Free Cash Flow -0.32
Particulars MAR 2020 (Values in Cr)
Net Income 0.49
Cash from Operations 4.91
Cash from Investing 1.00
Cash from Financing 0.00
Net change in Cash 5.84
Free Cash Flow 4.91
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2254.45 47.63 22.83 38191.74 1668.20 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 120.70
  • 26 Days 97.60
  • 10 Days 111.50
  • 50 Days 87.20
  • 12 Days 108.10
  • 100 Days 79.40
  • 20 Days 99.90
  • 200 Days 81.30
131.37
PIVOT
First Resistance 137.19
Second Resistance 148.81
Third Resistance 154.63
First Support 119.75
Second Support 113.93
Third Support 102.31
RSI 66.05
MACD 10.45
Commodity Channel Index (CCI) 121.69
ADX 33.94
Williams % R -43.76

Over 1 Month

down

56.67

Over 3 Months

down

70.76

Over 6 Months

down

92.04

Over 1 Year

down

147.52

Over 3 Years

down

58.13

Over 5 Years

down

78.44

CHEMO PHARMA LABORATORIES LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

CHEMO PHARMA LABORATORIES LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
71.74
Promoter Holdings
27.88
FII
0.0
DII
0.36
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Citric India Ltd Shareholding of Promoter and Promoter Group 369500.0 24.63
Shree Consultation And Services Pvt Ltd Public Shareholding 54500.0 3.63
Shanta Somani Shareholding of Promoter and Promoter Group 48781.0 3.25
Ravindra Somani Public Shareholding 47411.0 3.16
Sudhir Harilal Kale Public Shareholding 35000.0 2.33
Mahendrabhai Gulabdas Patel Public Shareholding 19150.0 1.28

CHEMO PHARMA LABORATORIES LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About CHEMO PHARMA LABORATORIES LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by CHEMO PHARMA LABORATORIES LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Chemo Pharma Laboratories Ltd?

Answer Field

The share price of Chemo Pharma Laboratories Ltd for NSE is ₹ 0.00 and for BSE is ₹ 119.43.

What is the Market Cap of Chemo Pharma Laboratories Ltd?

Answer Field

The market cap of Chemo Pharma Laboratories Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 17.90 Cr. as of now.

What is the 52 Week High and Low of Chemo Pharma Laboratories Ltd?

Answer Field

The 52 Week High and Low of Chemo Pharma Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 154.00 and ₹ 45.85.

How to Buy Chemo Pharma Laboratories Ltd share?

Answer Field

You can trade in Chemo Pharma Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Chemo Pharma Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 147.52%.

What is the Current Share Price of Chemo Pharma Laboratories Ltd?

Answer Field

Chemo Pharma Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 119.43 as on Dec 13 2024 03:23 PM.

What is the Market Cap of Chemo Pharma Laboratories Ltd Share?

Answer Field

The market cap of Chemo Pharma Laboratories Ltd for NSE ₹ 0.0 & for BSE ₹ 17.90 as on Dec 13 2024 03:23 PM.

What is the P/E Ratio of Chemo Pharma Laboratories Ltd Share?

Answer Field

As on Dec 13 2024 03:23 PM the price-to-earnings (PE) ratio for Chemo Pharma Laboratories Ltd share is 14.42.

What is the PB ratio of Chemo Pharma Laboratories Ltd Share?

Answer Field

As on Dec 13 2024 03:23 PM, the price-to-book (PB) ratio for Chemo Pharma Laboratories Ltd share is 91.06.

How to Buy Chemo Pharma Laboratories Ltd Share?

Answer Field

You can trade in Chemo Pharma Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Chemo Pharma Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Chemo Pharma Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Chemo Pharma Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader